MOH’s Proposed Patent Linkage Guideline Risks Higher Medicine Prices and Delayed Access
Malaysia stands at a critical juncture in ensuring access to affordable medicines. The government’s decision to cut the health budget by RM3.06 billion, together with a proposed move by the Ministry of Health, risks worsening the situation. In April, the National Pharmaceutical Regulatory Agency (NPRA) opened a public consultation on its proposed ‘Guideline on Implementation of Patent...
Read More